Do you want to read an article? Please log in or register.
Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension
Hypertension
Related content
Hypertension
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Lancet.
Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M; SPYRAL HTN-OFF MED trial investigators
doi: 10.1016/
Hypertension
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Lancet.
Agarwal R, Rossignol P, Romero A, Garza D, Mayo MR, Warren S, Ma J, White WB, Williams B
doi: 10.1016/S0140-6736(19)32135-X.
RECOMMENDED
Hypertension
Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension.
Hamdidouche I, Gosse P, Cremer A, Lorthioir A, Delsart P, Courand PY, Denolle T, Halimi JM, Girerd X, Ormezzano O, Rossignol P, Pereira H, Azizi M, DENERHTN Investigators.
doi: 10.1161/HYPERTENSIONAHA.119.13520.
Hypertension
Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial
Hypertension.
Lobo MD, Ott C, Sobotka PA, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Schmieder RE
doi: 10.1161/
Hypertension
Treatment of cyclosporine induced hypertension: Results from a long-term observational study using different antihypertensive medications
Vascul Pharmacol.
Marienhagen K, Lehner F, Klempnauer J, Hecker H, Borlak J
doi: 10.1016/j.vph.2018.06.012.
Hypertension
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study
Lancet.
Spiering W, Williams B, Van der Heyden J, van Kleef M, Lo R, Versmissen J, Moelker A, Kroon A, Reuter H, Ansel G, Stone GW, Bates M; CALM-FIM_EUR investigators
doi: 10.1016/S0140-
Hypertension
Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study
Hypertension.
Ghazi L, Cohen LP, Muntner P, Shimbo D, Drawz PE
doi: 10.1161/HYPERTENSIONAHA.
Hypertension
Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study
Am J Hypertens.
Chowdhury EK, Nelson MR, Ernst ME, Margolis KL, Beilin LJ, Johnston CI, Woods RL, Murray AM, Wolfe R, Storey E, Shah RC, Lockery JE, Tonkin AM, Newman AB, Williamson JD, Abhayaratna WP, Stocks NP, Fitzgerald SM, Orchard SG, Trevaks RE, Donnan GA, Grimm R, McNeil J, Reid CM, ASPREE Investigator Group.
doi: 10.1093/ajh/hpz192.
Hypertension
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
Lancet.
Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, Cohen SA, Fahy M, Pilcher G, Kario K; SPYRAL HTN-ON MED Trial Investigators
doi: 10.1016/